Last week’s hot topic on Scleroderma was about the Research of Lung Fibrosis in Scleroderma Revealing High Levels of Antibodies That Correlate with Disease Progression written by Margarida Azevedo.
The article is centered around the study about circulating antibodies against specific chemokine (small proteins with an important role in the immune system) receptors that exist in higher levels in patients with systemic sclerosis, and how these antibodies correlate with disease progression and clinical manifestations of the disease, such as lung fibrosis.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?